C12Y 601/01021
Histidine-trna ligase
Official title: Histidine-tRNA ligase (6.1.1.21)
C12Y601/01021 (Histidine-trna ligase) appears on 29 US grants and 41 published applications in this corpus.
Search patents in C12Y- Granted patents
- 29
- Published applications
- 41
- Assignees
- 7
- Inventors
- 62
- Latest grant
- 16 Dec 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2005 | 0 | 3 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 1 |
| 2011 | 0 | 0 |
| 2012 | 0 | 1 |
| 2013 | 1 | 5 |
| 2014 | 2 | 3 |
| 2015 | 1 | 4 |
| 2016 | 5 | 1 |
| 2017 | 4 | 7 |
| 2018 | 3 | 0 |
| 2019 | 2 | 3 |
| 2020 | 4 | 7 |
| 2021 | 3 | 1 |
| 2022 | 0 | 2 |
| 2023 | 1 | 1 |
| 2024 | 0 | 1 |
| 2025 | 3 | 0 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Compositions and methods comprising histidyl-tRNA synthetase splice variants having non-canonical biological activities16 Dec 2025US 12,497,466 B2aTyr Pharma, Inc.
- Histidyl-tRNA synthetase-Fc conjugates and therapeutics using the same9 Dec 2025US 12,492,392 B2aTyr Pharma, Inc.
- Molecules and methods for iterative polypeptide analysis and processing9 Dec 2025US 12,493,042 B2Washington University
- Compositions and methods for treating lung inflammation26 Sep 2023US 11,767,520 B2aTyr Pharma, Inc.
- Compositions and methods comprising histidyl-tRNA synthetase splice variants having non-canonical biological activities3 Aug 2021US 11,078,299 B2aTyr Pharma, Inc.
- Compositions and methods comprising histidyl-trna synthetase splice variants having non-canonical biological activities10 Sep 2026US 2026/0265411 A1aTyr Pharma, Inc.
- Molecules and methods for iterative polypeptide analysis and processing20 Jun 2024US 2024/0201199 A1Washington University
- Compositions and methods for treating nrp2-associated diseases9 Feb 2023US 2023/0039401 A1aTyr Pharma, Inc.
- Compositions and methods comprising histidyl-trna synthetase splice variants having non-canonical biological activities31 Mar 2022US 2022/0098327 A1aTyr Pharma, Inc.
- Histidyl-trna synthetase-fc conjugates31 Mar 2022US 2022/0098568 A1aTyr Pharma, Inc.
Most cited
By later US patents
- Compositions and methods comprising histidyl-tRNA synthetase splice variants having non-canonical biological activities87US 8,404,242 B2aTyr Pharma, Inc. · 2013
- Molecules and methods for iterative polypeptide analysis and processing57US 9,435,810 B2Washington University · 2016
- Histidyl-tRNA synthetase-Fc conjugates32US 9,587,235 B2aTyr Pharma, Inc. · 2017
- Histidyl-tRNA synthetase-Fc conjugates21US 10,093,915 B2aTyr Pharma, Inc. · 2018
- Compositions and methods comprising histidyl-TRNA synthetase splice variants having non-canonical biological activities20US 8,753,638 B2aTyr Pharma, Inc. · 2014